Interrelationship_of_blood_transfusion,_non-A,_non-B_hepatitis_and_hepatocellular_carcinoma:_analysis_by_detection_of_antibody_to_hepatitis_C_virus._To_clarify_the_relationship_between_hepatitis_C_virus_infection_and_the_development_of_hepatocellular_carcinoma_as_sequelae_of_non-A,_non-B_posttransfusion_hepatitis,_231_patients_with_chronic_non-A,_non-B_hepatitis_(96_with_chronic_hepatitis,_81_with_cirrhosis_and_54_with_hepatocellular_carcinoma)_were_analyzed_for_antibody_to_hepatitis_C_virus_and_were_compared_with_125_patients_with_chronic_hepatitis_B_(50_with_chronic_hepatitis,_46_with_cirrhosis_and_29_with_hepatocellular_carcinoma)._Antibody_to_hepatitis_C_virus_was_detected_in_89.6%,_86.4%_and_94.4%_of_patients_with_non-A,_non-B_hepatitis-related_chronic_hepatitis,_cirrhosis_and_hepatocellular_carcinoma,_respectively,_compared_with_6%,_17.4%_and_34.5%_with_similar_diseases_related_to_hepatitis_B._A_history_of_transfusion_was_documented_in_52%,_33%_and_42%_of_anti-hepatitis_C_virus-positive_cases_of_chronic_hepatitis,_cirrhosis_and_hepatocellular_carcinoma._The_mean_intervals_between_the_date_of_transfusion_and_the_date_of_diagnosis_of_anti-hepatitis_C_virus-positive_chronic_hepatitis,_cirrhosis_and_hepatocellular_carcinoma_were_10,_21.2_and_29_yr,_respectively._In_21_patients_with_transfusion-associated_hepatocellular_carcinoma,_anti-hepatitis_C_virus_was_present_in_each_serial_sample_available_for_testing,_including_samples_obtained_up_to_14_yr_before_the_diagnosis_of_hepatocellular_carcinoma._These_data_suggest_the_slow,_sequential_progression_from_acute_hepatitis_C_virus-related_non-A,_non-B_hepatitis_through_chronic_hepatitis_and_cirrhosis_to_hepatocellular_carcinoma_and_support_a_causal_association_between_hepatitis_C_virus_and_hepatocellular_carcinoma.